clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00398112 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2008-11-01 | |
P1050 | medical condition | leukemia | Q29496 |
lymphoma | Q208414 | ||
P2899 | minimum age | 18 | |
P1132 | number of participants | 18 | |
P6153 | research site | North Central Cancer Treatment Group | Q7054727 |
P580 | start time | 2007-08-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase II Study of Sunitinib Malate for Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) |
Search more.